Spire Wealth Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,195
| Closed | -$37.2K | – | 2528 |
|
|
2025
Q1 | $37.2K | Sell |
1,195
-954
| -44% | -$29.7K | ﹤0.01% | 1392 |
|
|
2024
Q4 | $54.8K | Buy |
2,149
+1,699
| +378% | +$43.3K | ﹤0.01% | 1248 |
|
|
2024
Q3 | $12.7K | Hold |
450
| – | – | ﹤0.01% | 1574 |
|
|
2024
Q2 | $11.9K | Hold |
450
| – | – | ﹤0.01% | 1597 |
|
|
2024
Q1 | $13.7K | Hold |
450
| – | – | ﹤0.01% | 1621 |
|
|
2023
Q4 | $13.1K | Hold |
450
| – | – | ﹤0.01% | 1671 |
|
|
2023
Q3 | $12.2K | Hold |
450
| – | – | ﹤0.01% | 1666 |
|
|
2023
Q2 | $13.8K | Hold |
450
| – | – | ﹤0.01% | 1716 |
|
|
2023
Q1 | $16.2K | Hold |
450
| – | – | ﹤0.01% | 1692 |
|
|
2022
Q4 | $18K | Hold |
450
| – | – | ﹤0.01% | 1411 |
|
|
2022
Q3 | $18K | Buy |
+450
| New | +$18K | ﹤0.01% | 1374 |
|